Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.470
+0.050 (3.52%)
Feb 13, 2026, 4:00 PM EST - Market closed

Pulmonx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
612684883151,1812,462
Market Cap Growth
-73.01%-45.11%54.88%-73.31%-52.01%-
Enterprise Value
412163911841,0062,687
Last Close Price
1.476.7912.758.4332.0769.02
PS Ratio
0.653.207.115.8824.4075.21
PB Ratio
1.013.134.132.056.1110.89
P/TBV Ratio
1.053.214.212.086.2011.02
EV/Sales Ratio
0.442.585.693.4220.7782.09
Debt / Equity Ratio
0.940.660.350.160.140.12
Net Debt / Equity Ratio
-0.33-0.52-0.76-0.80-0.85-0.90
Net Debt / EBITDA Ratio
0.360.831.492.153.546.42
Net Debt / FCF Ratio
0.611.372.342.643.656.48
Asset Turnover
0.600.490.370.250.190.21
Inventory Turnover
1.471.301.150.890.951.41
Quick Ratio
3.974.725.628.1310.6518.85
Current Ratio
4.865.586.509.1411.8519.96
Return on Equity (ROE)
-73.72%-55.25%-44.69%-33.94%-23.21%-26.41%
Return on Assets (ROA)
-23.38%-20.54%-20.84%-17.09%-11.85%-12.74%
Return on Capital Employed (ROCE)
-49.50%-40.40%-40.10%-33.50%-21.70%-12.90%
Earnings Yield
-93.60%-21.03%-12.46%-18.68%-4.12%-1.31%
FCF Yield
-53.72%-12.30%-7.87%-14.71%-3.81%-1.28%
Buyback Yield / Dilution
-3.66%-2.99%-2.37%-2.68%-254.74%-473.44%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q